Regulatory Updates
Sep 11, 2026•1 min read
FDA Approves ANDA077183 for Amlodipine Besylate and Benazepril Hydrochloride
The FDA has granted approval for ANDA077183, a prescription oral capsule combining amlodipine besylate and benazepril hydrochloride, manufactured by Dr. Reddy's Laboratories.
Regulatory Updates
Sep 10, 2026•1 min read
FDA approves ANDA090609 for atomoxetine capsules by Dr. Reddy's Laboratories
FDA has granted approval for ANDA090609, allowing Dr. Reddy's Laboratories to market generic atomoxetine hydrochloride oral capsules in multiple strengths.
Regulatory Updates
Aug 24, 2026•1 min read
FDA Approves Dr. Reddy's DESLORATADINE Oral Disintegrating Tablets (ANDA 078367)
The FDA has approved Dr. Reddy's Laboratories' DESLORATADINE oral disintegrating tablets in 2.5 mg and 5 mg strengths under ANDA 078367.